Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination.
Most existing studies characterizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell responses are peptide based. This does not allow evaluation of whether tested peptides are processed and presented canonically. In this study, we use recombinant vaccinia virus (rVACV)-m...
Autors principals: | Yin, Z, Chen, J-L, Lu, Y, Wang, B, Godfrey, L, Mentzer, AJ, Yao, X, Liu, G, Wellington, D, Zhao, Y, Wing, PAC, Dejnirattisa, W, Supasa, P, Liu, C, Hublitz, P, Beveridge, R, Waugh, C, Clark, S-A, Clark, K, Sopp, P, Rostron, T, Mongkolsapaya, J, Screaton, GR, Ogg, G, Ewer, K, Pollard, AJ, Gilbert, S, Knight, JC, Lambe, T, Smith, GL, Dong, T, Peng, Y |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Cell Press
2023
|
Ítems similars
-
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
per: Dejnirattisai, W, et al.
Publicat: (2021) -
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
per: Peng, Y, et al.
Publicat: (2020) -
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine
per: Watanabe, Y, et al.
Publicat: (2021) -
Why do breakthrough COVID-19 infections occur in the vaccinated?
per: Maclean, P, et al.
Publicat: (2021) -
Soaring higher with new spike
per: The Star, Y. P. Sivam
Publicat: (2009)